Skip to main content
NeuronFeed

Truveta vs Ubie

Which Healthcare AI tool is better in 2026?

Truveta

$515M

Ubie

$125M

Side-by-side

Verdict

Truveta is the more established option (raised $515M); pricing is comparable on both sides.

Metric Truveta Ubie
Taglinei
Foundedi 2020 2017🏆
HQi
Employeesi 11-50 11-50
Neuron scorei 75🏆 65
Total fundingi $515M🏆 $125M
Latest roundi Series C · Jan 2025 Series C
Valuationi $1B🏆
Cheapest paid plani Pricing not disclosed Pricing not disclosed
Free plani
Free triali
Top tier pricei Pricing not disclosed Pricing not disclosed
Pricing summaryi Free Free
Categoriesi

Capability matrix

Developer-facing capabilities and access signals for Truveta and Ubie.

Capability Truveta Ubie
MCP support
Public API
Webhooks
OAuth 2.0
SDK languages
Free plan
Free trial
Verified
Active deal

🟢 Strengths of Truveta

  • Has raised more capital ($515M vs $125M)
  • Higher Neuron score (75 vs 65)
  • Newer company (2020)

🔵 Strengths of Ubie

  • More mature (2017)

Which should you choose?

Choose Ubie if price matters most — it starts at Free, which is friendlier for teams watching burn. Both AI Healthcare tools ship core features, so the cost delta often decides it for small teams and solo operators.

Choose Truveta if you want the most established option — it has raised $515M, suggesting more runway for enterprise features, support, and long-term roadmap. For mission-critical workflows or larger teams, that stability often outweighs a lower monthly price.

Frequently asked questions

Truveta vs Ubie — which is better?

It depends on your priority. Truveta has raised more capital and is the more established option; Ubie has broader feature depth. See the side-by-side table above.

Is Truveta cheaper than Ubie?

No — Ubie's cheapest paid plan is Free, while Truveta's is Free.

Do Truveta and Ubie offer free plans?

Truveta: Yes, has a free plan. Ubie: Yes, has a free plan.

Contextual paths to related AI startups, deals and rankings.